Aspirin and Clopidogrel Taken Until 2 Days Prior to Coronary Artery Bypass Graft Surgery Is Associated with Increased Postoperative Drainage Loss

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

Objective: Platelet aggregation inhibitors, such as aspirin and clopidogrel, are associated with increased bleeding in patients undergoing cardiac surgery with cardiopulmonary bypass. We investigated the impact of time between the last intake of aspirin and clopidogrel before CABG surgery and drainage loss, transfusion requirements and rate of reoperation. Patients and Methods: The records of patients who had coronary artery bypass graft surgery (CABG) were reviewed for intake of aspirin and clopidogrel within 7 days prior to surgery. Drainage loss, transfusion requirements and rate of reoperation for bleeding within 5 days after the operation, were recorded. Results: Out of 261 analysed patients, 225 patients (86.2 %) had no anti-platelet medication and 36 patients (13.8 %) were on aspirin and clopidogrel. Aspirin and clopidogrel, taken all until 2 days prior to operation, were associated with a significantly higher postoperative blood loss (1840 mL [1230 - 3710] vs. 280 mL [185 - 765], p = 0.005 for one day and 850 mL [345 - 1725] vs. 277 mL [165 - 778], p = 0.026, for 2 days prior to surgery). The trend showed that patients in the study group received more platelet concentrates (PC: 5.3 % vs. 13.9 %, p = 0.067). The rate of reoperation for bleeding was not different (p = 0.25). Conclusion: Aspirin and clopidogrel up to 2 days prior to CABG were associated with a significantly higher postoperative drainage loss.

References

• 1 Yusuf S, Zhao F, Mehta S R, Chrolavicius S, Tognoni G, Fox K K. Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.  N Engl J Med. 2001;  345 494-502
  CrossrefPubMedGoogle Scholar
• 2 Dörr G, Schmidt G, Gräfe M, Regitz-Zagrosek V, Fleck E. Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.  J Cardiovasc Pharmacol. 2002;  39 523-532
  CrossrefPubMedGoogle Scholar
• 3 Yende S, Wunderink R G. Effect of clopidogrel on bleeding after coronary artery bypass surgery.  Crit Care Med. 2001;  29 2271-2275
  PubMedGoogle Scholar
• 4 Ray J G, Deniz S, Olivieri A, Pollex E, Vermeulen M J, Alexander K S, Cain D J, Cybulsky I, Hamielec C M. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel.  BMC Cardiovasc Disord. 2003;  3 3
  CrossrefPubMedGoogle Scholar
• 5 Hongo R H, Ley J, Dick S E, Yee R R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting.  J Am Coll Cardiol. 2002;  40 231-237
  PubMedGoogle Scholar
• 6 Fox K A, Mehta S R, Peters R, Zhao F, Lakkis N, Gersh B J, Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome. The clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial.  Circulation. 2004;  110 1202-1208
  CrossrefPubMedGoogle Scholar
• 7 Chopra V, Marmur J D, Cavusoglu E. The role of clopidogrel in the management of patients with ischemic heart disease.  Cardiovasc Drugs Ther. 2003;  17 467-477
  CrossrefPubMedGoogle Scholar
• 8 Saw J, Topol E J, Steinhubl S R, Brennan D, Berger P B, Moliterno D J. CREDO Investigators. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention.  Am J Cardiol. 2004;  94 623-625
  CrossrefPubMedGoogle Scholar
• 9 Calafiore A M, Teodori G, Mezzetti A, Bosco G, Verna A M, Di Giammarco G, Lapenna D. Intermittent antegrade warm blood cardioplegia.  Ann Thorac Surg. 1995;  59 398-402
  CrossrefPubMedGoogle Scholar
• 10 Caplain H, Donat F, Gaut C, Necciari J. Pharmacokinetics of clopidogrel.  Semin Thromb Hemost. 1999;  25 (Suppl 2) 25-28
  PubMedGoogle Scholar
• 11 Weber A A, Braun M, Hohlfeld T, Schwippert B, Tschope D, Schror K. Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers.  Br J Clin Pharmacol. 2001;  52 333-336
  CrossrefPubMedGoogle Scholar
• 12 Thebault J J, Kieffer G, Cariou R. Single-dose pharmacodynamics of clopidogrel.  Semin Thromb Hemost. 1999;  25 (Suppl 2) 3-8
  PubMedGoogle Scholar
• 13 Thebault J J, Kieffer G, Lowe G D, Nimmo W S, Cariou R. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.  Semin Thromb Hemost. 1999;  25 (Suppl 2) 9-14
  PubMedGoogle Scholar
• 14 Jones H U, Muhlestein J B, Jones K W, Bair T L, Lavasani F, Sohrevardi M, Horne B D, Doty D, Lappe D L. Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports.  Circulation. 2002;  106 (Suppl 1) I19-I22
  CrossrefPubMedGoogle Scholar
• 15 Pothula S, Sanchala V T, Nagappala B, Inchiosa Jr M A. The effect of preoperative antiplatelet/anticoagulant prophylaxis on postoperative blood loss in cardiac surgery.  Anesth Analg. 2004;  98 4-10
  PubMedGoogle Scholar
• 16 Patrono C. Aspirin as an antiplatelet drug.  N Engl J Med. 1994;  330 1287-1294
  CrossrefPubMedGoogle Scholar
• 17 Englberger L, Faeh B, Berdat P A, Eberli F, Meier B, Carrel T. Impact of clopidogrel in coronary artery bypass grafting.  Eur J Cardiothorac Surg. 2004;  26 96-101
  CrossrefPubMedGoogle Scholar
• 18 Ley S J. Quality care outcomes in cardiac surgery: the role of evidence-based practice.  AACN Clin Issues. 2001;  12 606-617
  PubMedGoogle Scholar
• 19 Karabulut H, Toraman F, Evrenkaya S, Goksel O, Tarcan S, Alhan C. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery.  Eur J Cardiothorac Surg. 2004;  25 419-423
  CrossrefPubMedGoogle Scholar
• 20 Rawitscher R E, Jones J W, McCoy T A, Lindsley D A. A prospective study of aspirin's effect on red blood cell loss in cardiac surgery.  J Cardiovasc Surg. 1991;  32 1-7
  PubMedGoogle Scholar
• 21 Karthik S, Grayson A D, McCarron E E, Pullan D M, Desmond M J. Re-exploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay.  Ann Thorac Surg. 2004;  78 527-534
  CrossrefPubMedGoogle Scholar
• 22 Tuman K J, McCarthy R J, O'Connor C J, McCarthy W E, Ivankovich A D. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery.  Anesth Analg. 1996;  83 1178-1184
  PubMedGoogle Scholar
• 23 Reich D L, Patel G C, Vela-Cantos F, Bodian C, Lansman S. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery.  Anesth Analg. 1994;  79 4-8
  PubMedGoogle Scholar
• 24 Moulton M J, Creswell L L, Mackey M E, Cox J L, Rosenbloom M. Re-exploration for bleeding is a risk factor for adverse outcomes after cardiac operations.  J Thorac Cardiovasc Surg. 1996;  111 1037-1046
  CrossrefPubMedGoogle Scholar

MD, DEAA Christian von Heymann

Department of Anesthesiology and Intensive Care Medicine
Charité - University Hospital Berlin
Charité Campus Mitte

Schumannstraße 20 - 21

10117 Berlin

Germany

Phone: + 4930450531012

Fax: + 49 3 04 50 53 19 11

Email: christian.von_heymann@charite.de